MedPath

Dexmedetomidine vs. Propofol for Cataract Surgery

Phase 4
Completed
Conditions
Cataract
Interventions
Registration Number
NCT00786370
Lead Sponsor
The Cooper Health System
Brief Summary

The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will be based on simple cardiorespiratory measures often associated with complications from sedation as well as assessment of the achieved sedation by the attending anesthesiologist and surgeon.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  1. Normal renal function
  2. No chronic use of narcotics
  3. ASA PS1-3
  4. Males or females age 18 or older
Exclusion Criteria
  1. Liver disease (Child Pugh classification 1-3)
  2. History of chronic use of sedatives, narcotics, alcohol or illicit drugs or allergy to any the study medications
  3. History of 1st and 2nd degree heart block (not paced)
  4. Any patient with EF < 30%
  5. Patients with active seizure history
  6. Pregnant patients (women of child bearing potential will have a preoperative pregnancy test as is standard of practice)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PropofolPropofol-
DexmedetomidineDexemedetomidine-
Dexmedetomidinedexmedetomidine-
Primary Outcome Measures
NameTimeMethod
To compare select cardiorespiratory effects of dexmedetomidine sedation to those of propofol sedation in patients undergoing cataract surgery.1 day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cooper University Hospital

🇺🇸

Camden, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath